Low-molecular-weight heparin as an adjunct to thrombolysis in ST elevation myocardial infarction.
Quinlan
Daniel J
DJ
Eikelboom
John W
JW
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D004562:Electrocardiography; D017984:Enoxaparin / Q000008:administration & dosage / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D055502:Secondary Prevention; D015912:Thrombolytic Therapy / Q000379:methods*; D013925:Thromboplastin / Q000187:drug effects / Q000378:metabolism; D016896:Treatment Outcome
D000925:Anticoagulants; D017984:Enoxaparin; D006495:Heparin, Low-Molecular-Weight; D013925:Thromboplastin